 | • レポートコード：D0GIR-01200 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がん治療・バイオ治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。がん治療・バイオ治療の種類別市場規模（化学療法、放射線療法、ホルモン療法、生物療法）、用途別市場規模（消費（販売）、家庭、病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bristol-Myers Squibb、Johnson & Johnson、Biogen IDEC、AstraZeneca、Novartis、Pfizer、Genentech、Sanofi、Roche and Schering-Plough ・地域別グローバル市場分析 2015年-2020年 ・がん治療・バイオ治療の北米市場（アメリカ、カナダ、メキシコ） ・がん治療・バイオ治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がん治療・バイオ治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がん治療・バイオ治療の南米市場（ブラジル、アルゼンチン） ・がん治療・バイオ治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法、放射線療法、ホルモン療法、生物療法 ・用途別分析：消費（販売）、家庭、病院 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Cancer Therapeutics And Biotherapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 10550 million by 2025, from USD 8959.4 million in 2019.
The Cancer Therapeutics And Biotherapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Therapeutics And Biotherapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Therapeutics And Biotherapeutics market has been segmented into:
Chemotherapy
Radiation Therapy
Hormone Therapy
Biotherapy
By Application, Cancer Therapeutics And Biotherapeutics has been segmented into:
Consumption (Sales)
Household
Hospital
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Therapeutics And Biotherapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Therapeutics And Biotherapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Therapeutics And Biotherapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Therapeutics And Biotherapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Therapeutics And Biotherapeutics Market Share Analysis
Cancer Therapeutics And Biotherapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Therapeutics And Biotherapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Therapeutics And Biotherapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Therapeutics And Biotherapeutics are:
Bristol-Myers Squibb
Johnson & Johnson
Biogen IDEC
AstraZeneca
Novartis
Pfizer
Genentech
Sanofi
Roche and Schering-Plough
Table of Contents
1 Cancer Therapeutics And Biotherapeutics Market Overview
1.1 Product Overview and Scope of Cancer Therapeutics And Biotherapeutics
1.2 Classification of Cancer Therapeutics And Biotherapeutics by Type
1.2.1 Global Cancer Therapeutics And Biotherapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Type in 2019
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.2.5 Hormone Therapy
1.2.6 Biotherapy
1.3 Global Cancer Therapeutics And Biotherapeutics Market by Application
1.3.1 Overview: Global Cancer Therapeutics And Biotherapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Consumption (Sales)
1.3.3 Household
1.3.4 Hospital
1.4 Global Cancer Therapeutics And Biotherapeutics Market by Regions
1.4.1 Global Cancer Therapeutics And Biotherapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Therapeutics And Biotherapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Therapeutics And Biotherapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Therapeutics And Biotherapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Therapeutics And Biotherapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Therapeutics And Biotherapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Therapeutics And Biotherapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bristol-Myers Squibb SWOT Analysis
2.1.4 Bristol-Myers Squibb Product and Services
2.1.5 Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Cancer Therapeutics And Biotherapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biogen IDEC
2.3.1 Biogen IDEC Details
2.3.2 Biogen IDEC Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biogen IDEC SWOT Analysis
2.3.4 Biogen IDEC Product and Services
2.3.5 Biogen IDEC Cancer Therapeutics And Biotherapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Cancer Therapeutics And Biotherapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Cancer Therapeutics And Biotherapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Cancer Therapeutics And Biotherapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genentech
2.7.1 Genentech Details
2.7.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Genentech SWOT Analysis
2.7.4 Genentech Product and Services
2.7.5 Genentech Cancer Therapeutics And Biotherapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SWOT Analysis
2.8.4 Sanofi Product and Services
2.8.5 Sanofi Cancer Therapeutics And Biotherapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche and Schering-Plough
2.9.1 Roche and Schering-Plough Details
2.9.2 Roche and Schering-Plough Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche and Schering-Plough SWOT Analysis
2.9.4 Roche and Schering-Plough Product and Services
2.9.5 Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Therapeutics And Biotherapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Therapeutics And Biotherapeutics Players Market Share
3.2.2 Top 10 Cancer Therapeutics And Biotherapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Therapeutics And Biotherapeutics Revenue and Market Share by Regions
4.2 North America Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
5 North America Cancer Therapeutics And Biotherapeutics Revenue by Countries
5.1 North America Cancer Therapeutics And Biotherapeutics Revenue by Countries (2015-2020)
5.2 USA Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
6 Europe Cancer Therapeutics And Biotherapeutics Revenue by Countries
6.1 Europe Cancer Therapeutics And Biotherapeutics Revenue by Countries (2015-2020)
6.2 Germany Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
6.4 France Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue by Countries
7.1 Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue by Countries (2015-2020)
7.2 China Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
7.5 India Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
8 South America Cancer Therapeutics And Biotherapeutics Revenue by Countries
8.1 South America Cancer Therapeutics And Biotherapeutics Revenue by Countries (2015-2020)
8.2 Brazil Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Therapeutics And Biotherapeutics by Countries
9.1 Middle East & Africa Cancer Therapeutics And Biotherapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Therapeutics And Biotherapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Therapeutics And Biotherapeutics Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Radiation Therapy Revenue Growth Rate (2015-2025)
10.5 Hormone Therapy Revenue Growth Rate (2015-2025)
10.6 Biotherapy Revenue Growth Rate (2015-2025)
11 Global Cancer Therapeutics And Biotherapeutics Market Segment by Application
11.1 Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Application (2015-2020)
11.2 Cancer Therapeutics And Biotherapeutics Market Forecast by Application (2019-2024)
11.3 Consumption (Sales) Revenue Growth (2015-2020)
11.4 Household Revenue Growth (2015-2020)
11.5 Hospital Revenue Growth (2015-2020)
12 Global Cancer Therapeutics And Biotherapeutics Market Size Forecast (2021-2025)
12.1 Global Cancer Therapeutics And Biotherapeutics Market Size Forecast (2021-2025)
12.2 Global Cancer Therapeutics And Biotherapeutics Market Forecast by Regions (2021-2025)
12.3 North America Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
12.6 South America Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cancer Therapeutics And Biotherapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Therapeutics And Biotherapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Therapeutics And Biotherapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Therapeutics And Biotherapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 6. Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Major Business
Table 7. Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Bristol-Myers Squibb SWOT Analysis
Table 9. Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Product and Solutions
Table 10. Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Johnson & Johnson Corporate Information, Location and Competitors
Table 12. Johnson & Johnson Cancer Therapeutics And Biotherapeutics Major Business
Table 13. Johnson & Johnson Cancer Therapeutics And Biotherapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Johnson & Johnson SWOT Analysis
Table 15. Johnson & Johnson Cancer Therapeutics And Biotherapeutics Product and Solutions
Table 16. Johnson & Johnson Cancer Therapeutics And Biotherapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Biogen IDEC Corporate Information, Location and Competitors
Table 18. Biogen IDEC Cancer Therapeutics And Biotherapeutics Major Business
Table 19. Biogen IDEC Cancer Therapeutics And Biotherapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Biogen IDEC SWOT Analysis
Table 21. Biogen IDEC Cancer Therapeutics And Biotherapeutics Product and Solutions
Table 22. Biogen IDEC Cancer Therapeutics And Biotherapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AstraZeneca Corporate Information, Location and Competitors
Table 24. AstraZeneca Cancer Therapeutics And Biotherapeutics Major Business
Table 25. AstraZeneca Cancer Therapeutics And Biotherapeutics Total Revenue (USD Million) (2017-2018)
Table 26. AstraZeneca SWOT Analysis
Table 27. AstraZeneca Cancer Therapeutics And Biotherapeutics Product and Solutions
Table 28. AstraZeneca Cancer Therapeutics And Biotherapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Cancer Therapeutics And Biotherapeutics Major Business
Table 31. Novartis Cancer Therapeutics And Biotherapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Cancer Therapeutics And Biotherapeutics Product and Solutions
Table 34. Novartis Cancer Therapeutics And Biotherapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Pfizer Corporate Information, Location and Competitors
Table 36. Pfizer Cancer Therapeutics And Biotherapeutics Major Business
Table 37. Pfizer Cancer Therapeutics And Biotherapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Pfizer SWOT Analysis
Table 39. Pfizer Cancer Therapeutics And Biotherapeutics Product and Solutions
Table 40. Pfizer Cancer Therapeutics And Biotherapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Genentech Corporate Information, Location and Competitors
Table 42. Genentech Cancer Therapeutics And Biotherapeutics Major Business
Table 43. Genentech Cancer Therapeutics And Biotherapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Genentech SWOT Analysis
Table 45. Genentech Cancer Therapeutics And Biotherapeutics Product and Solutions
Table 46. Genentech Cancer Therapeutics And Biotherapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Sanofi Corporate Information, Location and Competitors
Table 48. Sanofi Cancer Therapeutics And Biotherapeutics Major Business
Table 49. Sanofi Cancer Therapeutics And Biotherapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Sanofi SWOT Analysis
Table 51. Sanofi Cancer Therapeutics And Biotherapeutics Product and Solutions
Table 52. Sanofi Cancer Therapeutics And Biotherapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche and Schering-Plough Corporate Information, Location and Competitors
Table 54. Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Major Business
Table 55. Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Roche and Schering-Plough SWOT Analysis
Table 57. Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Product and Solutions
Table 58. Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Cancer Therapeutics And Biotherapeutics Revenue (Million USD) by Players (2015-2020)
Table 60. Global Cancer Therapeutics And Biotherapeutics Revenue Share by Players (2015-2020)
Table 61. Global Cancer Therapeutics And Biotherapeutics Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Regions (2015-2020)
Table 63. North America Cancer Therapeutics And Biotherapeutics Revenue by Countries (2015-2020)
Table 64. North America Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries (2015-2020)
Table 65. Europe Cancer Therapeutics And Biotherapeutics Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Cancer Therapeutics And Biotherapeutics Revenue by Countries (2015-2020)
Table 68. South America Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Cancer Therapeutics And Biotherapeutics Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries (2015-2020)
Table 71. Global Cancer Therapeutics And Biotherapeutics Revenue (Million USD) by Type (2015-2020)
Table 72. Global Cancer Therapeutics And Biotherapeutics Revenue Share by Type (2015-2020)
Table 73. Global Cancer Therapeutics And Biotherapeutics Revenue Forecast by Type (2021-2025)
Table 74. Global Cancer Therapeutics And Biotherapeutics Revenue by Application (2015-2020)
Table 75. Global Cancer Therapeutics And Biotherapeutics Revenue Share by Application (2015-2020)
Table 76. Global Cancer Therapeutics And Biotherapeutics Revenue Forecast by Application (2021-2025)
Table 77. Global Cancer Therapeutics And Biotherapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancer Therapeutics And Biotherapeutics Picture
Figure 2. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Radiation Therapy Picture
Figure 5. Hormone Therapy Picture
Figure 6. Biotherapy Picture
Figure 7. Cancer Therapeutics And Biotherapeutics Revenue Market Share by Application in 2019
Figure 8. Consumption (Sales) Picture
Figure 9. Household Picture
Figure 10. Hospital Picture
Figure 11. Global Cancer Therapeutics And Biotherapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Cancer Therapeutics And Biotherapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Cancer Therapeutics And Biotherapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Cancer Therapeutics And Biotherapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Cancer Therapeutics And Biotherapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cancer Therapeutics And Biotherapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Cancer Therapeutics And Biotherapeutics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Cancer Therapeutics And Biotherapeutics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Cancer Therapeutics And Biotherapeutics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Cancer Therapeutics And Biotherapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Regions in 2018
Figure 25. North America Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 28. South America Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 30. North America Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries in 2019
Figure 32. USA Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries in 2019
Figure 37. Germany Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 38. UK Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 39. France Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries in 2019
Figure 44. China Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 47. India Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 49. South America Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries in 2019
Figure 51. Brazil Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Cancer Therapeutics And Biotherapeutics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Cancer Therapeutics And Biotherapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Global Cancer Therapeutics And Biotherapeutics Revenue Share by Type (2015-2020)
Figure 60. Global Cancer Therapeutics And Biotherapeutics Revenue Share by Type in 2019
Figure 61. Global Cancer Therapeutics And Biotherapeutics Market Share Forecast by Type (2021-2025)
Figure 62. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 63. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Hormone Therapy Revenue Growth Rate (2015-2020)
Figure 65. Global Biotherapy Revenue Growth Rate (2015-2020)
Figure 66. Global Cancer Therapeutics And Biotherapeutics Revenue Share by Application (2015-2020)
Figure 67. Global Cancer Therapeutics And Biotherapeutics Revenue Share by Application in 2019
Figure 68. Global Cancer Therapeutics And Biotherapeutics Market Share Forecast by Application (2021-2025)
Figure 69. Global Consumption (Sales) Revenue Growth Rate (2015-2020)
Figure 70. Global Household Revenue Growth Rate (2015-2020)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Cancer Therapeutics And Biotherapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Cancer Therapeutics And Biotherapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
Figure 76. Europe Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
Figure 78. South America Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Cancer Therapeutics And Biotherapeutics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
頭頸部がん治療薬/治療剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Head and Neck Cancer Drugs/Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1466.9 million by 2025, from USD 1255.8 million in 2019. …- 膀胱癌治療・診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bladder Cancer Therapeutics and Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 551.5 million by 2025, from USD 427.6 million in 2019…
- 膵臓がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pancreatic Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pancreatic Can…
- 樹状細胞がんワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dendritic Cell Cancer Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dendritic Cell …
- 骨癌診断・治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bone Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bone C…